Abstract
Autism spectrum disorder is a pervasive neurodevelopmental disorder with a substantial contribution to the global disease burden. Despite intensive research efforts, the aetiopathogenesis remains unclear. The Janus-faced antioxidant enzymes superoxide dismutase 1–3 have been implicated in initiating oxidative stress and as such may constitute a potential therapeutic target. However, no measurement has been taken in human autistic brain samples. The aim of this study is to measure superoxide dismutase 1–3 in autistic cerebral organoids as an in vitro model of human foetal neurodevelopment. Whole brain organoids were created from induced pluripotent stem cells from healthy individuals (n = 5) and individuals suffering from autism (n = 4). Using Pierce bicinchoninic acid and enzyme-linked immunosorbent assays, the protein and superoxide dismutase 1, 2, and 3 concentrations were quantified in the cerebral organoids at days 22, 32, and 42. Measurements were normalized to the protein concentration. Results represented using medians and interquartile ranges. Using Wilcoxon matched-pairs signed-rank test, an abrupt rise in the superoxide dismutase concentration was observed at day 32 and onwards. Using Wilcoxon rank-sum test, no differences were observed between healthy (SOD1: 35.56 ng/mL ± 3.46; SOD2: 2435.80 ng/mL ± 1327.00; SOD3: 1854.88 ng/mL ± 867.94) and autistic (SOD1: 32.85 ng/mL ± 5.26; SOD2: 2717.80 ng/mL ± 1889.10; SOD3: 1690.18 ng/mL ± 615.49) organoids. Cerebral organoids recapitulate many aspects of human neurodevelopment, but the diffusion restriction may render efforts in modelling differences in oxidative stress futile due to the intrinsic hypoxia and central necrosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Upon reasonable request, the raw data can be accessed by contacting the corresponding author.
References
Ao Z, Cai H, Havert DJ, Wu Z, Gong Z, Beggs JM, Mackie K, Guo F (2020) One-stop microfluidic assembly of human brain organoids to model prenatal cannabis exposure. Anal Chem 92(6):4630–4638. https://doi.org/10.1021/acs.analchem.0c00205
Bhaduri A, Andrews MG, Mancia Leon W, Jung D, Shin D, Allen D, Jung D, Schmunk G, Haeussler M, Salma J, Pollen AA, Nowakowski TJ, Kriegstein AR (2020) Cell stress in cortical organoids impairs molecular subtype specification. Nature 578(7793):142–148. https://doi.org/10.1038/s41586-020-1962-0
Bjørklund G, Tinkov AA, Hosnedlová B, Kizek R, Ajsuvakova OP, Chirumbolo S, Skalnaya MG, Peana M, Dadar M, El-Ansary A, Qasem H, Adams JB, Aaseth J, Skalny AV (2020) The role of glutathione redox imbalance in autism spectrum disorder: a review. Free Radic Biol Med 160:149–162. https://doi.org/10.1016/j.freeradbiomed.2020.07.017
Boisvert EM, Means RE, Michaud M, Madri JA, Katz SG (2019) Minocycline mitigates the effect of neonatal hypoxic insult on human brain organoids. Cell Death Dis 10(4):325. https://doi.org/10.1038/s41419-019-1553-x
Camp JG, Badsha F, Florio M, Kanton S, Gerber T, Wilsch-Bräuninger M, Lewitus E, Sykes A, Hevers W, Lancaster M, Knoblich JA, Lachmann R, Pääbo S, Huttner WB, Treutlein B (2015) Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. Proc Natl Acad Sci USA 112(51):15672–15677. https://doi.org/10.1073/pnas.1520760112
Chen L, Shi XJ, Liu H, Mao X, Gui LN, Wang H, Cheng Y (2021) Oxidative stress marker aberrations in children with autism spectrum disorder: a systematic review and meta-analysis of 87 studies (N = 9109). Transl Psychiatry 11(1):15. https://doi.org/10.1038/s41398-020-01135-3
Cho AN, Jin Y, An Y, Kim J, Choi YS, Lee JS, Kim J, Choi WY, Koo DJ, Yu W, Chang GE, Kim DY, Jo SH, Kim J, Kim SY, Kim YG, Kim JY, Choi N, Cheong E, Kim YJ, Je HS, Kang HC, Cho SW (2021) Microfluidic device with brain extracellular matrix promotes structural and functional maturation of human brain organoids. Nat Commun 12(1):4730. https://doi.org/10.1038/s41467-021-24775-5
Choe MS, Kim SJ, Oh ST, Bae CM, Choi WY, Baek KM, Kim JS, Lee MY (2021) A simple method to improve the quality and yield of human pluripotent stem cell-derived cerebral organoids. Heliyon 7(6):e07350. https://doi.org/10.1016/j.heliyon.2021.e07350
Daviaud N, Friedel RH, Zou H (2018) Vascularization and engraftment of transplanted human cerebral organoids in mouse cortex. eNeuro. https://doi.org/10.1523/eneuro.0219-18.2018
Daviaud N, Chevalier C, Friedel RH, Zou H (2019) Distinct vulnerability and resilience of human neuroprogenitor subtypes in cerebral organoid model of prenatal hypoxic injury. Front Cell Neurosci 13:336. https://doi.org/10.3389/fncel.2019.00336
Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcín C, Montiel-Nava C, Patel V, Paula CS, Wang C, Yasamy MT, Fombonne E (2012) Global prevalence of autism and other pervasive developmental disorders. Autism Res 5(3):160–179. https://doi.org/10.1002/aur.239
Eyring KW, Geschwind DH (2021) Three decades of ASD genetics: building a foundation for neurobiological understanding and treatment. Hum Mol Genet 30(20):R236–R244. https://doi.org/10.1093/hmg/ddab176
Fair SR, Julian D, Hartlaub AM, Pusuluri ST, Malik G, Summerfied TL, Zhao G, Hester AB, Ackerman WET, Hollingsworth EW, Ali M, McElroy CA, Buhimschi IA, Imitola J, Maitre NL, Bedrosian TA, Hester ME (2020) Electrophysiological maturation of cerebral organoids correlates with dynamic morphological and cellular development. Stem Cell Rep 15(4):855–868. https://doi.org/10.1016/j.stemcr.2020.08.017
Frustaci A, Neri M, Cesario A, Adams JB, Domenici E, Dalla Bernardina B, Bonassi S (2012) Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med 52(10):2128–2141. https://doi.org/10.1016/j.freeradbiomed.2012.03.011
Giandomenico SL, Mierau SB, Gibbons GM, Wenger LMD, Masullo L, Sit T, Sutcliffe M, Boulanger J, Tripodi M, Derivery E, Paulsen O, Lakatos A, Lancaster MA (2019) Cerebral organoids at the air–liquid interface generate diverse nerve tracts with functional output. Nat Neurosci 22(4):669–679. https://doi.org/10.1038/s41593-019-0350-2
Giandomenico SL, Sutcliffe M, Lancaster MA (2021) Generation and long-term culture of advanced cerebral organoids for studying later stages of neural development. Nat Protoc 16(2):579–602. https://doi.org/10.1038/s41596-020-00433-w
Glorieux C, Calderon PB (2017) Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach. Biol Chem 398(10):1095–1108. https://doi.org/10.1515/hsz-2017-0131
Ilieva M, Fex Svenningsen Å, Thorsen M, Michel TM (2018) Psychiatry in a dish: stem cells and brain organoids modeling autism spectrum disorders. Biol Psychiatry 83(7):558–568. https://doi.org/10.1016/j.biopsych.2017.11.011
Jögi A, Øra I, Nilsson H, Lindeheim A, Makino Y, Poellinger L, Axelson H, Påhlman S (2002) Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 99(10):7021–7026. https://doi.org/10.1073/pnas.102660199
Kamand M, Ilieva M, Forsberg SL, Thomassen M, Fex Svenningsen Å, Holst B, Meyer M, Michel TM (2020a) Generation of human induced pluripotent stem cells (SDUKIi002-A) from a 22-year-old male diagnosed with autism spectrum disorder. Stem Cell Res 46:101834. https://doi.org/10.1016/j.scr.2020a.101834
Kamand M, Ilieva M, Forsberg SL, Thomassen M, Svenningsen ÅF, Meyer M, Michel TM (2020b) Generation of autism spectrum disorder patient-derived iPSC line SDUKIi004-A. Stem Cell Res 49:102038. https://doi.org/10.1016/j.scr.2020b.102038
Kamand M, Ilieva M, Louise Forsberg S, Thomassen M, Meyer M, Fex Svenningsen Å, Maria Michel T (2020c) Derivation of induced pluripotent stem cells (SDUKIi003-A) from a 20-year-old male patient diagnosed with Asperger syndrome. Stem Cell Res 48:101974. https://doi.org/10.1016/j.scr.2020c.101974
Kamand M, Forsberg SL, Thomassen M, Ilieva M, Meyer M, Svenningsen ÅF, Michel TM (2021) Establishment of an induced pluripotent stem (iPS) cell line (SDUKIi006-A) from a 21-year old male patient diagnosed with atypical autism disorder. Stem Cell Res 51:102185. https://doi.org/10.1016/j.scr.2021.102185
Kanton S, Boyle MJ, He Z, Santel M, Weigert A, Sanchís-Calleja F, Guijarro P, Sidow L, Fleck JS, Han D, Qian Z, Heide M, Huttner WB, Khaitovich P, Pääbo S, Treutlein B, Camp JG (2019) Organoid single-cell genomic atlas uncovers human-specific features of brain development. Nature 574(7778):418–422. https://doi.org/10.1038/s41586-019-1654-9
Kathuria A, Lopez-Lengowski K, Watmuff B, Karmacharya R (2020) Comparative transcriptomic analysis of cerebral organoids and cortical neuron cultures derived from human induced pluripotent stem cells. Stem Cells Dev 29(21):1370–1381. https://doi.org/10.1089/scd.2020.0069
Kim MS, Kim DH, Kang HK, Kook MG, Choi SW, Kang KS (2021) Modeling of hypoxic brain injury through 3D human neural organoids. Cells. https://doi.org/10.3390/cells10020234
Kovač J, Macedoni Lukšič M, Trebušak Podkrajšek K, Klančar G, Battelino T (2014) Rare single nucleotide polymorphisms in the regulatory regions of the superoxide dismutase genes in autism spectrum disorder. Autism Res 7(1):138–144. https://doi.org/10.1002/aur.1345
Lancaster MA, Knoblich JA (2014) Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc 9(10):2329–2340. https://doi.org/10.1038/nprot.2014.158
Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, Homfray T, Penninger JM, Jackson AP, Knoblich JA (2013) Cerebral organoids model human brain development and microcephaly. Nature 501(7467):373–379. https://doi.org/10.1038/nature12517
Levy A, Perry A (2011) Outcomes in adolescents and adults with autism: a review of the literature. Res Autism Spectr Disord 5(4):1271–1282. https://doi.org/10.1016/j.rasd.2011.01.023
Liao X, Liu Y, Fu X, Li Y (2020) Postmortem studies of neuroinflammation in autism spectrum disorder: a systematic review. Mol Neurobiol 57(8):3424–3438. https://doi.org/10.1007/s12035-020-01976-5
Logan S, Arzua T, Yan Y, Jiang C, Liu X, Yu LK, Liu QS, Bai X (2020) Dynamic characterization of structural, molecular, and electrophysiological phenotypes of human-induced pluripotent stem cell-derived cerebral organoids, and comparison with fetal and adult gene profiles. Cells. https://doi.org/10.3390/cells9051301
Luo C, Lancaster MA, Castanon R, Nery JR, Knoblich JA, Ecker JR (2016) Cerebral organoids recapitulate epigenomic signatures of the human fetal brain. Cell Rep 17(12):3369–3384. https://doi.org/10.1016/j.celrep.2016.12.001
Mahony C, O’Ryan C (2021) Convergent canonical pathways in autism spectrum disorder from proteomic, transcriptomic and DNA methylation data. Int J Mol Sci. https://doi.org/10.3390/ijms221910757
Main PA, Angley MT, O’Doherty CE, Thomas P, Fenech M (2012) The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis. Nutr Metab (lond) 9:35. https://doi.org/10.1186/1743-7075-9-35
Mansour AA, Gonçalves JT, Bloyd CW, Li H, Fernandes S, Quang D, Johnston S, Parylak SL, Jin X, Gage FH (2018) An in vivo model of functional and vascularized human brain organoids. Nat Biotechnol 36(5):432–441. https://doi.org/10.1038/nbt.4127
Miao L, St Clair DK (2009) Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 47(4):344–356. https://doi.org/10.1016/j.freeradbiomed.2009.05.018
Ng F, Berk M, Dean O, Bush AI (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11(6):851–876. https://doi.org/10.1017/s1461145707008401
NICE (2013) Autism spectrum disorder in under 19s: support and management [Internet]. ([updated 2021 June] ed.). National Institue for Health and Care Excellence. https://www.nice.org.uk/guidance/conditions-and-diseases/mental-health-and-behavioural-conditions/autism/products?ProductType=Guidance&Status=Published. Accessed 15 Dec 2021
Nzou G, Wicks RT, VanOstrand NR, Mekky GA, Seale SA, El-Taibany A, Wicks EE, Nechtman CM, Marrotte EJ, Makani VS, Murphy SV, Seeds MC, Jackson JD, Atala AJ (2020) Multicellular 3D neurovascular unit model for assessing hypoxia and neuroinflammation induced blood–brain barrier dysfunction. Sci Rep 10(1):9766. https://doi.org/10.1038/s41598-020-66487-8
Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8(5):409–412. https://doi.org/10.1038/nmeth.1591
Pangrazzi L, Balasco L, Bozzi Y (2020) Oxidative stress and immune system dysfunction in autism spectrum disorders. Int J Mol Sci. https://doi.org/10.3390/ijms21093293
Pașca AM, Park JY, Shin HW, Qi Q, Revah O, Krasnoff R, O’Hara R, Willsey AJ, Palmer TD, Pașca SP (2019) Human 3D cellular model of hypoxic brain injury of prematurity. Nat Med 25(5):784–791. https://doi.org/10.1038/s41591-019-0436-0
Quadrato G, Nguyen T, Macosko EZ, Sherwood JL, Min Yang S, Berger DR, Maria N, Scholvin J, Goldman M, Kinney JP, Boyden ES, Lichtman JW, Williams ZM, McCarroll SA, Arlotta P (2017) Cell diversity and network dynamics in photosensitive human brain organoids. Nature 545(7652):48–53. https://doi.org/10.1038/nature22047
Ramaekers VT, Sequeira JM, Thöny B, Quadros EV (2020) Oxidative stress, folate receptor autoimmunity, and CSF findings in severe infantile autism. Autism Res Treat 2020:9095284. https://doi.org/10.1155/2020/9095284
Rasmussen MA, Holst B, Tümer Z, Johnsen MG, Zhou S, Stummann TC, Hyttel P, Clausen C (2014) Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage. Stem Cell Rep 3(3):404–413. https://doi.org/10.1016/j.stemcr.2014.07.006
Redcay E, Courchesne E (2005) When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry 58(1):1–9. https://doi.org/10.1016/j.biopsych.2005.03.026
Renner M, Lancaster MA, Bian S, Choi H, Ku T, Peer A, Chung K, Knoblich JA (2017) Self-organized developmental patterning and differentiation in cerebral organoids. EMBO J 36(10):1316–1329. https://doi.org/10.15252/embj.201694700
Rossignol DA, Frye RE (2012) Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17(3):290–314. https://doi.org/10.1038/mp.2010.136
Rothenbücher TSP, Gürbüz H, Pereira MP, Heiskanen A, Emneus J, Martinez-Serrano A (2021) Next generation human brain models: engineered flat brain organoids featuring gyrification. Biofabrication 13(1):011001. https://doi.org/10.1088/1758-5090/abc95e
Sacco R, Gabriele S, Persico AM (2015) Head circumference and brain size in autism spectrum disorder: a systematic review and meta-analysis. Psychiatry Res 234(2):239–251. https://doi.org/10.1016/j.pscychresns.2015.08.016
Saghazadeh A, Ataeinia B, Keynejad K, Abdolalizadeh A, Hirbod-Mobarakeh A, Rezaei N (2019a) Anti-inflammatory cytokines in autism spectrum disorders: a systematic review and meta-analysis. Cytokine 123:154740. https://doi.org/10.1016/j.cyto.2019a.154740
Saghazadeh A, Ataeinia B, Keynejad K, Abdolalizadeh A, Hirbod-Mobarakeh A, Rezaei N (2019b) A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: effects of age, gender, and latitude. J Psychiatr Res 115:90–102. https://doi.org/10.1016/j.jpsychires.2019.05.019
Savino R, Carotenuto M, Polito AN, Di Noia S, Albenzio M, Scarinci A, Ambrosi A, Sessa F, Tartaglia N, Messina G (2020) Analyzing the potential biological determinants of autism spectrum disorder: from neuroinflammation to the Kynurenine pathway. Brain Sci. https://doi.org/10.3390/brainsci10090631
Stamova BS, Tian Y, Nordahl CW, Shen MD, Rogers S, Amaral DG, Sharp FR (2013) Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders. Mol Autism 4(1):30. https://doi.org/10.1186/2040-2392-4-30
Thorsen M, Bilenberg N, Thorsen L, Michel TM (2021) Oxidative stress in adults with autism spectrum disorder: a case control study. J Autism Dev Disord. https://doi.org/10.1007/s10803-021-04897-x
Urresti J, Zhang P, Moran-Losada P, Yu NK, Negraes PD, Trujillo CA, Antaki D, Amar M, Chau K, Pramod AB, Diedrich J, Tejwani L, Romero S, Sebat J, Yates Iii JR, Muotri AR, Iakoucheva LM (2021) Cortical organoids model early brain development disrupted by 16p11.2 copy number variants in autism. Mol Psychiatry. https://doi.org/10.1038/s41380-021-01243-6
Vangipuram M, Ting D, Kim S, Diaz R, Schüle B (2013) Skin punch biopsy explant culture for derivation of primary human fibroblasts. J vis Exp 7(77):e3779. https://doi.org/10.3791/3779
Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T (2013) Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382(9904):1575–1586. https://doi.org/10.1016/s0140-6736(13)61611-6
Woolfenden S, Sarkozy V, Ridley G, Williams K (2012) A systematic review of the diagnostic stability of autism spectrum disorder. Res Autism Spectr Disord 6(1):345–354. https://doi.org/10.1016/j.rasd.2011.06.008
World Health O (2018) International classification of diseases for mortality and morbidity statistics, vol 11. World Health Organization. https://www.icd.who.int/en/. Accessed 15 Dec 2021
Yenkoyan K, Harutyunyan H, Harutyunyan A (2018) A certain role of SOD/CAT imbalance in pathogenesis of autism spectrum disorders. Free Radic Biol Med 123:85–95. https://doi.org/10.1016/j.freeradbiomed.2018.05.070
Zelko IN, Mariani TJ, Folz RJ (2002) Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33(3):337–349. https://doi.org/10.1016/s0891-5849(02)00905-x
Zhang S, Deng L, Jia Q, Huang S, Gu J, Zhou F, Gao M, Sun X, Feng C, Fan G (2017) dbMDEGA: a database for meta-analysis of differentially expressed genes in autism spectrum disorder. BMC Bioinform 18(1):494. https://doi.org/10.1186/s12859-017-1915-2
Zuber TJ (2002) Punch biopsy of the skin. Am Fam Physician 65(6):1155–1158 (1161–1152, 1164)
Funding
The research group is funded by the Research Foundation for Psychiatric Research in the Region of Southern Denmark and covers the running cost of daily activities and salaries. The funding source had no influence on the research.
Author information
Authors and Affiliations
Contributions
ME: investigation, formal analysis, visualization, and writing (original draft). MI: conceptualization, methodology, supervision, and writing (review and editing). TMM: conceptualization, methodology, resources, supervision, project administration, funding acquisition, and writing (review and editing).
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial, non-financial, or competing interests to disclose in any material discussed in this article.
Ethics
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by The Research Ethics Committee of the Region of Southern Denmark, DK (S-20160103).
Consent
Informed consent was obtained from all cell line donors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ejlersen, M., Ilieva, M. & Michel, T.M. Superoxide dismutase isozymes in cerebral organoids from autism spectrum disorder patients. J Neural Transm 129, 617–626 (2022). https://doi.org/10.1007/s00702-022-02472-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-022-02472-x